Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)

Jin Matsuyama,Tetsuji Terazawa,Masahiro Goto,Ryohei Kawabata,Shunji Endo,Motohiro Imano,Shoichiro Fujita,Yusuke Akamaru,Hirokazu Taniguchi,Mitsutoshi Tatsumi,Sang-Woong Lee, Hisato Kawakami,Yukinori Kurokawa,Toshio Shimokawa,Daisuke Sakai,Takeshi Kato,Kazumasa Fujitani,Taroh Satoh

The Oncologist, 2022, 27, 251–e304